XSNX

NovAccess Global Inc. XSNX

XSNX
NovAccess Global Inc. PXMD
PaxMedica, Inc. Common Stock VAXX
Vaxxinity, Inc. NNLX
NanoLogix, Inc. OZYMF
Strategic Partners A/S HLUN
HEALTHeUNIVERSE, Inc. TRVN
Trevena, Inc. QBIO
Q BioMed Inc. EVLO
Evelo Biosciences, Inc. ARDS
Aridis Pharmaceuticals, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode XSNX PXMD VAXX NNLX OZYMF HLUN TRVN QBIO EVLO ARDS
6M -66.67 % 0.00 % -75.00 % 0.00 % 0.00 % -50.00 % -98.91 % 9 900.00 % 0.00 % 2 200.00 %
YTD -92.31 % -99.85 % 150.00 % 0.00 % 0.00 % -50.00 % -99.25 % 9 900.00 % 0.00 % 2 200.00 %
1Y -98.08 % -99.85 % 3 025.00 % 0.00 % 0.00 % -50.00 % -99.24 % 9 900.00 % 0.00 % 2 200.00 %
3Y -99.96 % -100.00 % -99.19 % 0.00 % -40.00 % -90.00 % -99.97 % -99.23 % -100.00 % -99.78 %
5Y -99.98 % -100.00 % -99.92 % -99.86 % -99.27 % -90.00 % -100.00 % -99.99 % -100.00 % -99.96 %
10Y -100.00 % -100.00 % -99.92 % -99.83 % -98.95 % -80.00 % -100.00 % -100.00 % -100.00 % -99.98 %
Depuis le début -100.00 % -100.00 % -99.92 % -99.97 % -98.95 % -90.00 % -100.00 % -99.98 % -100.00 % -99.98 %

Dividende